Waddell & Reed Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Waddell & Reed Financial's LLY Position: Q1 2021 in Review
Waddell & Reed Financial increased its Eli Lilly (LLY) stake by 16% in Q1 2021, buying an estimated $24.9M and bringing the position to 939,366 shares worth $175M. The position accounts for 0.36% of the portfolio, ranked #70.
Waddell & Reed Financial first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $181M in Q4 2017. 1,949 funds tracked by Wall St. Rank hold LLY as of Q1 2021.
- Waddell & Reed Financial held 939,366 shares of Eli Lilly worth $175M as of Q1 2021.
- Waddell & Reed Financial bought 127,287 Eli Lilly shares in Q1 2021, an estimated $24.9M.
- Eli Lilly made up 0.36% of Waddell & Reed Financial's portfolio in Q1 2021, its #70 holding.
- Waddell & Reed Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- Waddell & Reed Financial's Eli Lilly position peaked at $181M in Q4 2017.
- 1,949 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.
Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.